FRAG-RIP

Contents Vial: Tyr-hGH Fragment 177-191 lyophilised powder 2mg.
Ampoule: 2ml Sterile water for injection.
Administration Intramuscular or Subcutaneous injection.
Storage Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution.
Dosage Initial: 5 mcg/kg/day empty stomach. May increase dose gradually. Max: 12 mcg/kg/day.
Contraindications Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment.
Special Precautions DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis.
Adverse Drug Reactions Side effects noted are tiredness, feeling of lethargy, head rush or euphoria, itching. Loss of glycaemic control in diabetics.
Drug Interactions High doses of corticosteroid may inhibit growth-promoting effects of HGH Fragment 177-191